USA - NYSE:RELX - US7595301083 - ADR
The current stock price of RELX is 41.725 USD. In the past month the price decreased by -5.69%. In the past year, price decreased by -11.9%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VRSK | VERISK ANALYTICS INC | 30.38 | 29.45B | ||
| EFX | EQUIFAX INC | 26.97 | 25.67B | ||
| LDOS | LEIDOS HOLDINGS INC | 17.01 | 25.32B | ||
| J | JACOBS SOLUTIONS INC | 26.8 | 18.42B | ||
| ULS | UL SOLUTIONS INC - CLASS A | 49.63 | 17.35B | ||
| TRU | TRANSUNION | 19.28 | 15.77B | ||
| CACI | CACI INTERNATIONAL INC -CL A | 21.84 | 13.18B | ||
| BAH | BOOZ ALLEN HAMILTON HOLDINGS | 14.35 | 10.84B | ||
| PSN | PARSONS CORP | 27.23 | 9.31B | ||
| KBR | KBR INC | 11.12 | 5.48B | ||
| AMTM | AMENTUM HOLDINGS INC | 11.07 | 5.58B | ||
| FCN | FTI CONSULTING INC | 18.9 | 5.25B |
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. The firm operates in four market segments: Risk; Scientific, Technical & Medical; Legal, and Exhibitions. The Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. The Scientific, Technical & Medical segment helps researchers and healthcare professionals advance science and improve health outcomes by combining high-quality scientific and medical information. The Legal segment provides legal, regulatory and business information and analytics. The Exhibitions segment combines industry expertise with data and digital tools to help customers connect face-to-face and digitally, learn about markets, source products and complete transactions.
RELX PLC - SPON ADR
1-3 Strand
London WC2N 5JR GB
CEO: Erik Engstrom
Employees: 35490
Phone: 442071665777
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. The firm operates in four market segments: Risk; Scientific, Technical & Medical; Legal, and Exhibitions. The Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. The Scientific, Technical & Medical segment helps researchers and healthcare professionals advance science and improve health outcomes by combining high-quality scientific and medical information. The Legal segment provides legal, regulatory and business information and analytics. The Exhibitions segment combines industry expertise with data and digital tools to help customers connect face-to-face and digitally, learn about markets, source products and complete transactions.
The current stock price of RELX is 41.725 USD. The price decreased by -1.29% in the last trading session.
RELX PLC - SPON ADR (RELX) has a dividend yield of 1.94%. The yearly dividend amount is currently 0.8.
RELX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
23 analysts have analysed RELX and the average price target is 55.26 USD. This implies a price increase of 32.44% is expected in the next year compared to the current price of 41.725.
The next ex-dividend date for RELX PLC - SPON ADR (RELX) is August 8, 2025.
You can find the ownership structure of RELX PLC - SPON ADR (RELX) on the Ownership tab.
ChartMill assigns a fundamental rating of 6 / 10 to RELX. While RELX belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
Over the last trailing twelve months RELX reported a non-GAAP Earnings per Share(EPS) of 1.38. The EPS increased by 3.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.19% | ||
| ROA | 13.44% | ||
| ROE | 88.3% | ||
| Debt/Equity | 2.57 |
23 analysts have analysed RELX and the average price target is 55.26 USD. This implies a price increase of 32.44% is expected in the next year compared to the current price of 41.725.
For the next year, analysts expect an EPS growth of 7.01% and a revenue growth 2.07% for RELX